Stereotactic body radiation therapy for pulmonary large cell neuroendocrine carcinoma: a case reportopen access
- Authors
- Jo, In Young; Yeo, Seung-Gu
- Issue Date
- 2019
- Publisher
- Dove Medical Press Ltd
- Keywords
- lung; large cell; neuroendocrine carcinoma; stereotactic ablative radiotherapy; radiation therapy
- Citation
- OncoTargets and Therapy, v.12, pp 1359 - 1364
- Pages
- 6
- Journal Title
- OncoTargets and Therapy
- Volume
- 12
- Start Page
- 1359
- End Page
- 1364
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/5346
- DOI
- 10.2147/OTT.S189858
- ISSN
- 1178-6930
- Abstract
- The incidence of large cell neuroendocrine carcinoma (LCNEC) of the lung is rare, and the treatment methods and prognosis for such patients are still subjects of debate. We report a case of a 78-year-old male LCNEC patient for whom stereotactic body radiation therapy was performed. A four-dimensional computed tomography scan was used for simulation, and radiotherapy was planned using the volumetrically modulated arc technique. A total of 55 Gy was delivered in five daily fractions. The treatment was safely completed, and the patient did not report any discomfort. The only side-effect was an intermittent cough. Currently, the patient has received 18 months of outpatient follow-up care with no evidence of disease. In conclusion, stereotactic body radiation therapy can be a valuable treatment option for early stage LCNEC.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Radiation Oncology > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/5346)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.